CA2066429A1 - Raccordement de tissus par laser avec un produit contenant une teinture - Google Patents
Raccordement de tissus par laser avec un produit contenant une teintureInfo
- Publication number
- CA2066429A1 CA2066429A1 CA002066429A CA2066429A CA2066429A1 CA 2066429 A1 CA2066429 A1 CA 2066429A1 CA 002066429 A CA002066429 A CA 002066429A CA 2066429 A CA2066429 A CA 2066429A CA 2066429 A1 CA2066429 A1 CA 2066429A1
- Authority
- CA
- Canada
- Prior art keywords
- tissue
- energy
- contacting
- soldering
- dye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003466 welding Methods 0.000 title claims abstract description 56
- 229910000679 solder Inorganic materials 0.000 title description 8
- 238000005476 soldering Methods 0.000 claims abstract description 56
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 49
- 238000000034 method Methods 0.000 claims abstract description 36
- 239000011358 absorbing material Substances 0.000 claims abstract description 29
- 108010049003 Fibrinogen Proteins 0.000 claims abstract description 26
- 102000008946 Fibrinogen Human genes 0.000 claims abstract description 26
- 229940012952 fibrinogen Drugs 0.000 claims abstract description 26
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims abstract description 16
- 230000000694 effects Effects 0.000 claims abstract description 14
- 238000010521 absorption reaction Methods 0.000 claims abstract description 10
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 42
- 239000000203 mixture Substances 0.000 claims description 24
- 241001465754 Metazoa Species 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 claims description 9
- 229960004657 indocyanine green Drugs 0.000 claims description 9
- 108090000190 Thrombin Proteins 0.000 claims description 8
- 229960004072 thrombin Drugs 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- 239000012190 activator Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 108010088751 Albumins Proteins 0.000 claims description 5
- 102000009027 Albumins Human genes 0.000 claims description 5
- 102000004506 Blood Proteins Human genes 0.000 claims description 5
- 108010017384 Blood Proteins Proteins 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 229920001184 polypeptide Polymers 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 102000016359 Fibronectins Human genes 0.000 claims description 3
- 108010067306 Fibronectins Proteins 0.000 claims description 3
- 108010071289 Factor XIII Proteins 0.000 claims description 2
- 229940012444 factor xiii Drugs 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 238000001429 visible spectrum Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 67
- 239000000975 dye Substances 0.000 description 56
- 241001016380 Reseda luteola Species 0.000 description 51
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 31
- 229910052786 argon Inorganic materials 0.000 description 21
- 210000000709 aorta Anatomy 0.000 description 14
- -1 argon ion Chemical class 0.000 description 14
- 150000002500 ions Chemical class 0.000 description 14
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 230000003872 anastomosis Effects 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 208000014674 injury Diseases 0.000 description 9
- 108010073385 Fibrin Proteins 0.000 description 8
- 102000009123 Fibrin Human genes 0.000 description 8
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 229950003499 fibrin Drugs 0.000 description 8
- 230000008439 repair process Effects 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 6
- 230000009172 bursting Effects 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 230000001427 coherent effect Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 208000005422 Foreign-Body reaction Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 210000000702 aorta abdominal Anatomy 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 239000001046 green dye Substances 0.000 description 3
- 210000003701 histiocyte Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 241000272522 Anas Species 0.000 description 2
- 241000272525 Anas platyrhynchos Species 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- UOACKFBJUYNSLK-XRKIENNPSA-N Estradiol Cypionate Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H](C4=CC=C(O)C=C4CC3)CC[C@@]21C)C(=O)CCC1CCCC1 UOACKFBJUYNSLK-XRKIENNPSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- MDPILPRLPQYEEN-UHFFFAOYSA-N aluminium arsenide Chemical compound [As]#[Al] MDPILPRLPQYEEN-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- 238000002428 photodynamic therapy Methods 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000011268 retreatment Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960005356 urokinase Drugs 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 2
- 229960001600 xylazine Drugs 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 241000507564 Aplanes Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical compound CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000631130 Chrysophyllum argenteum Species 0.000 description 1
- 241000518994 Conta Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010083687 Ion Pumps Proteins 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 101100270435 Mus musculus Arhgef12 gene Proteins 0.000 description 1
- 101001041615 Oryctolagus cuniculus Corticostatin-4 Proteins 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000277284 Salvelinus fontinalis Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 241001665167 Solter Species 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 241000613130 Tima Species 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003364 biologic glue Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- OGGXGZAMXPVRFZ-UHFFFAOYSA-M dimethylarsinate Chemical compound C[As](C)([O-])=O OGGXGZAMXPVRFZ-UHFFFAOYSA-M 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- JBBPTUVOZCXCSU-UHFFFAOYSA-L dipotassium;2',4',5',7'-tetrabromo-4,7-dichloro-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [K+].[K+].O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(Br)=C([O-])C(Br)=C1OC1=C(Br)C([O-])=C(Br)C=C21 JBBPTUVOZCXCSU-UHFFFAOYSA-L 0.000 description 1
- 238000011833 dog model Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000002283 elective surgery Methods 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000004023 fresh frozen plasma Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000033687 granuloma formation Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229960003569 hematoporphyrin Drugs 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 229910052743 krypton Inorganic materials 0.000 description 1
- 101150085091 lat-2 gene Proteins 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000002406 microsurgery Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000009991 pite Nutrition 0.000 description 1
- 244000293655 pite Species 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000003685 thermal hair damage Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
- B23K26/00—Working by laser beam, e.g. welding, cutting or boring
- B23K26/18—Working by laser beam, e.g. welding, cutting or boring using absorbing layers on the workpiece, e.g. for marking or protecting purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/04—Surgical instruments, devices or methods for suturing wounds; Holders or packages for needles or suture materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00491—Surgical glue applicators
- A61B2017/00513—Tissue soldering
- A61B2017/00517—Tissue soldering using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
- A61B2017/22085—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance light-absorbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Otolaryngology (AREA)
- Optics & Photonics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Electromagnetism (AREA)
- Plasma & Fusion (AREA)
- Mechanical Engineering (AREA)
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
- Table Devices Or Equipment (AREA)
- Radiation-Therapy Devices (AREA)
- Laser Surgery Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40629789A | 1989-09-12 | 1989-09-12 | |
| US406,297 | 1989-09-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2066429A1 true CA2066429A1 (fr) | 1991-03-13 |
Family
ID=23607356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002066429A Abandoned CA2066429A1 (fr) | 1989-09-12 | 1990-09-11 | Raccordement de tissus par laser avec un produit contenant une teinture |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0491794A4 (fr) |
| JP (1) | JPH05502386A (fr) |
| AU (1) | AU646406B2 (fr) |
| CA (1) | CA2066429A1 (fr) |
| GR (1) | GR900100687A (fr) |
| IE (1) | IE903303A1 (fr) |
| IL (1) | IL95664A (fr) |
| WO (1) | WO1991004073A1 (fr) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5484432A (en) * | 1985-09-27 | 1996-01-16 | Laser Biotech, Inc. | Collagen treatment apparatus |
| AU1444292A (en) * | 1991-02-13 | 1992-09-15 | Interface Biomedical Laboratories Corp. | Filler material for use in tissue welding |
| US5749895A (en) * | 1991-02-13 | 1998-05-12 | Fusion Medical Technologies, Inc. | Method for bonding or fusion of biological tissue and material |
| US5669934A (en) * | 1991-02-13 | 1997-09-23 | Fusion Medical Technologies, Inc. | Methods for joining tissue by applying radiofrequency energy to performed collagen films and sheets |
| US5118452A (en) * | 1991-04-05 | 1992-06-02 | Nestle S.A. | Method of attaching a haptic to an optic of an intraocular lens |
| US5752949A (en) * | 1991-10-29 | 1998-05-19 | Thermolase Corporation | Hair removal method |
| US5713845A (en) * | 1991-10-29 | 1998-02-03 | Thermolase Corporation | Laser assisted drug delivery |
| US5817089A (en) * | 1991-10-29 | 1998-10-06 | Thermolase Corporation | Skin treatment process using laser |
| US5226907A (en) * | 1991-10-29 | 1993-07-13 | Tankovich Nikolai I | Hair removal device and method |
| US5752948A (en) * | 1991-10-29 | 1998-05-19 | Thermolase Corporation | Hair removal method |
| US5197649A (en) * | 1991-10-29 | 1993-03-30 | The Trustees Of Columbia University In The City Of New York | Gastrointestinal endoscoptic stapler |
| US5871480A (en) * | 1991-10-29 | 1999-02-16 | Thermolase Corporation | Hair removal using photosensitizer and laser |
| US5425728A (en) * | 1991-10-29 | 1995-06-20 | Tankovich; Nicolai I. | Hair removal device and method |
| EG20471A (en) | 1993-07-12 | 1999-05-31 | Thermotrex Corp | Hair removal device and method |
| CA2131750C (fr) * | 1994-07-26 | 2000-11-21 | Nikolai I. Tankovich | Methode d'epilation |
| US5989244A (en) * | 1994-11-15 | 1999-11-23 | Gregory; Kenton W. | Method of use of a sheet of elastin or elastin-based material |
| US6087552A (en) * | 1994-11-15 | 2000-07-11 | Sisters Of Providence Of Oregon | Method of producing fused biomaterials and tissue |
| US6372228B1 (en) | 1994-11-15 | 2002-04-16 | Kenton W. Gregory | Method of producing elastin, elastin-based biomaterials and tropoelastin materials |
| US7001328B1 (en) | 1994-11-15 | 2006-02-21 | Kenton W. Gregory | Method for using tropoelastin and for producing tropoelastin biomaterials |
| AU711199B2 (en) * | 1995-01-20 | 1999-10-07 | Macquarie Research Limited | Method of tissue repair |
| AUPN066795A0 (en) | 1995-01-20 | 1995-02-16 | Macquarie Research Limited | Method of repair |
| US5713891A (en) * | 1995-06-02 | 1998-02-03 | Children's Medical Center Corporation | Modified solder for delivery of bioactive substances and methods of use thereof |
| US6050990A (en) * | 1996-12-05 | 2000-04-18 | Thermolase Corporation | Methods and devices for inhibiting hair growth and related skin treatments |
| US6113636A (en) * | 1997-11-20 | 2000-09-05 | St. Jude Medical, Inc. | Medical article with adhered antimicrobial metal |
| WO1999051282A1 (fr) * | 1998-04-06 | 1999-10-14 | Cornell Research Foundation, Inc. | Composition pour la cicatrisation de tissus et procede associe d'utilisation |
| AUPP421498A0 (en) * | 1998-06-18 | 1998-07-09 | Macquarie Research Limited | Method of tissue repair |
| US6680063B1 (en) | 1999-10-08 | 2004-01-20 | Providence Health System-Oregon | Biocompatible albumin lamina and method |
| US7073510B2 (en) | 2000-02-11 | 2006-07-11 | The General Hospital Corporation | Photochemical tissue bonding |
| CA2399414A1 (fr) | 2000-02-11 | 2001-08-16 | The General Hospital Corporation | Liaison tissulaire photochimique |
| US8215314B2 (en) | 2000-02-11 | 2012-07-10 | The General Hospital Corporation | Photochemical tissue bonding |
| US20020156058A1 (en) * | 2000-08-17 | 2002-10-24 | Borkan William N. | Medical methods using catheters |
| WO2005079690A1 (fr) * | 2004-02-20 | 2005-09-01 | Keio University | Dispositif de fermeture de trou d’extraction de gaine utilisant un schéma de soudage laser |
| ITFI20060270A1 (it) * | 2006-10-31 | 2008-05-01 | Consiglio Nazionale Ricerche | Formulazioni di cromofori di impiago nella saldatura laser di tessuti biologici |
| WO2008065464A2 (fr) * | 2006-11-28 | 2008-06-05 | Universita' Degli Studi Di Padova | Méthode pour aérostase pulmonaire et dispositif de mise en oeuvre de cette méthode |
| EP2011524A1 (fr) * | 2007-07-02 | 2009-01-07 | Omrix Biopharmaceuticals Ltd. | Colle de fibrine avec agent de visualisation |
| US9433700B2 (en) | 2009-04-27 | 2016-09-06 | Medibeacon Inc. | Tissue sealant compositions, vascular closure devices, and uses thereof |
| US8388613B1 (en) | 2010-04-09 | 2013-03-05 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Methods and apparatus for microwave tissue welding for wound closure |
| DE102011057184A1 (de) * | 2011-12-30 | 2013-07-04 | Technische Universität Ilmenau | Vorrichtungen zum Verschliessen offener Wunden und zur Bearbeitung von Gewebe eines menschlichen oder tierischen Körpers |
| US9353092B2 (en) | 2013-06-27 | 2016-05-31 | University Of Notre Dame Du Lac | Synthesis and use of croconaine compounds |
| CN112336910B (zh) * | 2019-08-08 | 2022-05-13 | 南京理工大学 | 一种含icg染料的激光生物组织焊接助焊剂 |
| CN112957124B (zh) * | 2021-01-30 | 2023-08-22 | 南京理工大学 | 一种能量靶向调控的离体激光生物组织焊接缝合方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3769963A (en) * | 1972-03-31 | 1973-11-06 | L Goldman | Instrument for performing laser micro-surgery and diagnostic transillumination of living human tissue |
| US4457992A (en) * | 1983-05-09 | 1984-07-03 | Allied Corporation | Etchable electrophotographic long-run printing plate and method of making same |
| US4733039A (en) * | 1985-05-06 | 1988-03-22 | General Electric Company | Method of laser soldering |
| US4774339A (en) * | 1987-08-10 | 1988-09-27 | Molecular Probes, Inc. | Chemically reactive dipyrrometheneboron difluoride dyes |
| US4805623A (en) * | 1987-09-04 | 1989-02-21 | Vander Corporation | Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment |
-
1990
- 1990-09-11 IE IE330390A patent/IE903303A1/en unknown
- 1990-09-11 WO PCT/US1990/005125 patent/WO1991004073A1/fr not_active Ceased
- 1990-09-11 AU AU64071/90A patent/AU646406B2/en not_active Ceased
- 1990-09-11 CA CA002066429A patent/CA2066429A1/fr not_active Abandoned
- 1990-09-11 EP EP19900913764 patent/EP0491794A4/en not_active Withdrawn
- 1990-09-11 JP JP2513053A patent/JPH05502386A/ja active Pending
- 1990-09-12 IL IL9566490A patent/IL95664A/en not_active IP Right Cessation
- 1990-09-12 GR GR900100687A patent/GR900100687A/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6407190A (en) | 1991-04-18 |
| JPH05502386A (ja) | 1993-04-28 |
| IL95664A (en) | 1995-08-31 |
| IE903303A1 (en) | 1991-04-10 |
| WO1991004073A1 (fr) | 1991-04-04 |
| IL95664A0 (en) | 1991-06-30 |
| GR900100687A (el) | 1992-01-20 |
| AU646406B2 (en) | 1994-02-24 |
| EP0491794A1 (fr) | 1992-07-01 |
| EP0491794A4 (en) | 1992-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2066429A1 (fr) | Raccordement de tissus par laser avec un produit contenant une teinture | |
| Chuck et al. | Dye‐enhanced laser tissue welding | |
| Oz et al. | Tissue soldering by use of indocyanine green dye-enhanced fibrinogen with the near infrared diode laser | |
| US5824015A (en) | Method for welding biological tissue | |
| McNally et al. | Optimal parameters for laser tissue soldering. Part I: tensile strength and scanning electron microscopy analysis | |
| White et al. | Biological effects of laser welding on vascular healing | |
| O'Neill et al. | Microvascular anastomosis using a photochemical tissue bonding technique | |
| Vale et al. | Microsurgical anastomosis of rat carotid arteries with the CO2 laser | |
| US5498259A (en) | Method for fusing bone | |
| Bass et al. | Sutureless microvascular anastomosis using the THC: YAG laser: a preliminary report | |
| Wadia et al. | Liver repair and hemorrhage control by using laser soldering of liquid albumin in a porcine model | |
| Bleustein et al. | Semi‐solid albumin solder improved mechanical properties for laser tissue welding | |
| Kopchok et al. | Thermal studies of in-vivo vascular tissue fusion by argon laser | |
| Tang et al. | Microarterial anastomosis using a noncontact diode laser versus a control study | |
| Reali et al. | Experimental diode laser-assisted microvascular anastomosis | |
| Perito et al. | Laser-assisted enterocystoplasty in rats | |
| Samonte et al. | Laser‐assisted microvascular anastomosis using CO2 and KTP/532 lasers | |
| Wadia et al. | Sutureless liver repair and hemorrhage control using laser-mediated fusion of human albumin as a solder | |
| Sultan et al. | Separate and combined use of Nd-YAG and carbon dioxide lasers in liver resections: A preliminary report | |
| Sorensen et al. | Morphological and surface temperature changes in femoral arteries following laser irradiation | |
| Rosemberg | Clinical use of carbon dioxide (CO2) laser in microsurgical vasovasostomy | |
| Bass et al. | Laparoscopic applications of laser-activated tissue glues | |
| Xie et al. | Intraluminal albumin stent assisted laser welding for ureteral anastomosis | |
| Ashton Jr et al. | Laser-assisted fibrinogen bonding of vascular tissue | |
| Oz et al. | Strength of laser vascular fusion: preliminary observations on the role of thrombus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |